Elective lung resection cases
Conditions
Interventions
Flurubiprofen administration on anesthesia induction
Flurbiprofen administration on wound closure
Sponsors
Hyogo Cancer Center Department of Anesthesia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Elective lung resection cases scheduled for left thoracotomy
Exclusion criteria
Exclusion criteria: History of flurbiprofen allergy Active asthma Chronic kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative heart rate Intraoperative dose of phenylephrine and ephedrine Intraoperative infusion, transufusion, urine output, blood loss and fluid balance (ml/kg/h) Postoperative dose of flurbiprofen. Postoperative dose of phenylephrine. Postoperative infusion, transufusion, urine output, blood loss and fluid balance (ml/kg/h). Count of blood cells(WBC, RBC, hemoglobin, platelets) and biochemical tests (Alb, AST, ALP, LDH, BUN, Cr, CRP) on 1 and 7 postoperative day. ICU stay days. Hospital stay days. | — |
Countries
Japan
Contacts
Public ContactHiromi Katoh
Hyogo Cancer Center Department of Anesthesia
Outcome results
None listed